ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Advanced Search

Efficacy of Radiofrequency Ablation in the Treatment of Patients with Hepatocellular Carcinoma and Compensated Liver Disease: A Pathological Evaluation of Liver Explants

W. Alhamoudi1, I. Salih2, S. Yousif2, M. Shawkat3, K. Bzeizi2, A. Albenmousa2, S. Alghamdi2, M. Sturdevant2, D. Broering2, H. Alsuhaibani2

1Medicine, King Saud University, Riyadh, Saudi Arabia, 2Liver Transplant, King Faisal Specialist Hospital, Riyadh, Saudi Arabia, 3Internal Medicine, Minia University, Minia, Egypt

Meeting: 2020 American Transplant Congress

Abstract number: A-139

Keywords: Hepatocellular carcinoma, Histology, Liver transplantation, Radiologic assessment

Session Information

Date: Saturday, May 30, 2020

Session Name: Poster Session A: Liver: Hepatocellular Carcinoma and Other Malignancies

Session Time: 3:15pm-4:00pm

 Presentation Time: 3:30pm-4:00pm

Location: Virtual

Related Abstracts
  • Re-Evaluation of Imaging Studies in Patients with Hepatocellular Carcinoma at a Transplant Center Impacts Patient Care.
  • Recurrence of Hepatocellular Carcinoma After Transarterial Chemoembolization (TACE) Alone and TACE in Combination With Other Treatment Modalities

*Purpose: Radiofrequency ablation (RFA) is a safe and effective treatment for patients with limited hepatocellular carcinoma (HCC). Ablative outcomes have been largely based on radiological response, and confirmatory data based on histological review are limited. The aim of this study is to correlate the radiological tumor response of RFA with the histopathologic examination of explanted livers following liver transplantation (LT).

*Methods: All compensated patients treated with RFA prior to LT at our institution from 2007-2018 were included in this study. Clinical, pathological explant evaluation and survival outcomes were collected from our prospectively collected database.

*Results: 29 patients were treated with RFA prior to LT. Mean age was 58 years (range 21-75). The average time between RFA and LT was 8 months (range 1-24). The etiology of liver disease was as follows: HCV 13 (44.8%), HBV 9 (31%), Non-alcoholic steatohepatitis 5 (17.2%) and progressive familial intrahepatic cholestasis 2 (7%). 12(41%), 12 (41%), and 5 (18%) of patients had a single, two, or three lesions, respectively. 17 (58.6 %), 8 (27.6%), 3 (10.3%), and 1 (3.4%) received 1, 2, 3, and 4 sessions, respectively. Average pretreatment alfa fetoprotein was 139 (range 3.5-2159). When comparing RFA for single or multiple HCC with no lesion more than 3 cm pathological cure was significantly higher, 85% (12/14) of cases vs 46% (7/15) in patients with lesions exceeding 3 cm (p value=0.027). Pathological cure was 100% (4/4) in patients with a single lesion less than 3 cm. Furthermore, 6 patients had lesions on the explant examination that was not demonstrated on the pretransplant imaging, of them 5 patients had multifocal HCC while the remaining patient had a 4.2 cm lesion prior to RFA. Two patients developed new lesions on follow up imaging prior to LT. None of the included patients developed post-transplant HCC recurrence during the post-LT follow up period (54 months, range 1-131 months) and the overall survival was 76%.

*Conclusions: The HCC histopathologic characteristics in the explanted liver at the time of LT has a dual function in both reflecting the efficacy of preoperative locoregional therapy and as a predictive factor for HCC recurrence. Our data suggests that RFA can afford HCC patients excellent short-term tumor control even when their cancer is multifocal in nature, provided that the largest tumor is < 3 cm. This study also provides further evidence that modern imaging is still fallible in demonstrating active HCC especially in those with multifocal tumors prior to RFA.

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Alhamoudi W, Salih I, Yousif S, Shawkat M, Bzeizi K, Albenmousa A, Alghamdi S, Sturdevant M, Broering D, Alsuhaibani H. Efficacy of Radiofrequency Ablation in the Treatment of Patients with Hepatocellular Carcinoma and Compensated Liver Disease: A Pathological Evaluation of Liver Explants [abstract]. Am J Transplant. 2020; 20 (suppl 3). https://atcmeetingabstracts.com/abstract/efficacy-of-radiofrequency-ablation-in-the-treatment-of-patients-with-hepatocellular-carcinoma-and-compensated-liver-disease-a-pathological-evaluation-of-liver-explants/. Accessed January 23, 2021.

« Back to 2020 American Transplant Congress

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
    • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
    • Penis Transplantation: First U.S. Experience.
    • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
    • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
    • Live Related Kidney Transplant Experience in Abuja, Nigeria – First Eight Cases Ever.
    • Home
    • Search
    • Penis Transplantation: First U.S. Experience.
    • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
    • Low GFR after Kidney Donation Is Not Chronic Kidney Disease

    Visit Our Partner Sites

    American Transplant Congress (ATC)

    Visit the official site for the American Transplant Congress »

    American Journal of Transplantation

    The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

    American Society of Transplantation (AST)

    An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

    American Society of Transplant Surgeons (ASTS)

    The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

    Copyright © 2013-2021 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

    Privacy Policy

    loading Cancel
    Post was not sent - check your email addresses!
    Email check failed, please try again
    Sorry, your blog cannot share posts by email.
    This site uses cookies: Find out more.